chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP), Program ID:  The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INJURY (non-serious), outcome "unknown", described as "Injured by your COVID vaccines"; MOBILITY DECREASED (non-serious), outcome "unknown", described as "Limited mobility in my right arm".  Additional information: Patient was injured by your COVID vaccines, patient have limited mobility in right arm. Patient would provide the documented proof of your vaccines. Patient offering you and your lawyers the opportunity to a private out-of court personal injury settlement without patient Lawyers involvement. Patient asking to contact if you are interested in a private settlement.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Pain around the injection site; swelling around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Pain around the injection site) and INJECTION SITE SWELLING (swelling around the injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     Concurrent medical conditions included Sulfonamide allergy. Concomitant products included CHLORTHALIDONE, AMLODIPINE, ATORVASTATIN, GABAPENTIN and SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced INJECTION SITE PAIN (Pain around the injection site) and INJECTION SITE SWELLING (swelling around the injection site). On 13-Mar-2021, INJECTION SITE PAIN (Pain around the injection site) and INJECTION SITE SWELLING (swelling around the injection site) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Products known to have been used by the patient, within two weeks prior to the event, included alfaquin eye drops for an unknown indication.    Treatment of the events included, paracetamol and cold compress.
On 4-18-2021, I started to have severe sharp pain on the right side of my head. It appeared to be at the corner of my skull, about 3? above the right ear, where the convex top of my skull meets the flat right side of my skull. The pain was on & off and increased with my stress level.
My cousin almost died; This is a spontaneous report from a contactable consumer.  A patient of unspecified age and gender received bnt162b2 (COMIRNATY), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunization.  Medical history and concomitant medications were not reported.  The reporter asked on how to know if the vaccine was close to the expiration date and if there was a possibility of something happening to the vaccine (does it form a fungus). The reporter also asked what happen when vaccine was stored outside of recommendation. As it was stated that the reporter's cousin almost died on unknown date. Outcome of the event was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Body aches, chills, exhaustion, fever, injection site itching, swelling and redness.
No symptoms being reported; Inadvertently received an expired dose; Information has been received from a certified medical assistant concerning to a 4 week old patient (gender not reported). No medical history, concurrent conditions nor concomitant medications were reported. On 23-JAN-2020, the patient was vaccinated with an expire dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) (Lot No. N009802, exp. date 20-DEC-2019) first dose immunization series. No symptoms were reported.
Swelling in and tenderness in lymph node under right arm for 4 days proceeding Moderna booster vaccine. The swelling gradually abated on it's own without medical intervention.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 26-FEB-2007, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided) at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended. Instead, the patient contracted a persistent strain of shingles, or severe herpes zoster. On or about 11-APR-2014, the patient was treated by a physician for the onset of a rash, which was diagnosed as herpes zoster. The patient was prescribed VALTREX, gabapentin, and prednisone for management of his painful symptoms and chronic pain. As a direct and proximate result of the defective ZOSTAVAX vaccine, the patient suffered and continues to suffer painful and ongoing injuries and damages, and required and continues to require extensive medical care and treatment. As a further proximate result of the ZOSTAVAX vaccine, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
January 27 shot January 28, 7:00 pm- 3 hives on left arm with itching - started low doses of benadryl on Jan 29 January 29- more hives on arm - continued benadryl February 3 7:00 pm -sandpaper rash, bumps and severe itching on face, 2 lumps along jawline - predominately on left side - stopped benadryl, switched to Zyrtec on Feb 4 Feb 5 7:00 pm - rash & sever itching down back of neck, left shoulder - Famotidine added as well as steroid cream for non-face aeas All stages were handled via telephone conversations with Doctor's office
Patient was administered an extra booster dose of the Covid vaccine despite receiving the booster on 11/3 from his long-term care facility.
A couple of days after receiving the vaccine, the patient reports having soreness approximately 6 inches from her axilla, down her left arm. She denies any redness or warmth and has not had any fevers. She also reports that she is not palpating any mass, or lumps. She reports that it appears at times that the soreness has resolved and then she will notice it again.
After receiving her Pfizer booster vaccine on October 4, she reported swollen lymph nodes under her left armpit (the same arm where she received the vaccine. This swelling had not resolved yet when she reported it to the pharmacy on October 10. She reported that her left hand swelled up, and that she lost hearing temporarily in her left ear.
Patient was given the Moderna covid 19 vaccine on the morning of Saturday May 1. His wife came in to the pharmacy today (5/5/21) and explained his adverse reaction which started Sunday evening. His symptoms included high temp (102.8), confusion, blue lips, bad headache, decrease in blood pressure He was taken by his wife to local hospital then transferred to another facility. His wife said he had sepsis. He was treated and released from hospital. She said he still had a headache.
Child developed red maculopapular rash on face and trunk, and left thigh. Resolved over 15 minutes, no breathing problems, patient was alert and playful.
Patient described redness below injection along with fever (101 degrees F) - s/p 24 hours; Patient described redness on trunk s/p 48 hours; Redness was not raised, warm to touch, or itchy.
02/03/2021-Tachycardia,  admitted to hospital  and diagnosed with Afib 02/05/2021- cardio version procedure to return heart to normal rhythm  Discharged that afternoon
24 hours post-injection, developed intestinal cramping and diarrhea, which resolved after taking Imodium.  Also felt feverish and generally poor for another c. 30 hours.  Then after about a week developed a very itchy rash on my chest which has not yet fully resolved.
Fever chills; Headache; Severe fatigue; Mild fever (100.7),; Asthma also seemed mildly agitated; Cough; Body aches; This is a spontaneous report from a contactable healthcare professional. A 29-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 08May2021 at 12:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included  COVID-19 on 16Apr2021, asthma, gastrooesophageal reflux disease (GERD) and currently strained psoas muscles since an unspecified date. The patient had unspecified allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included fluticasone furoate/vilanterol trifenatate (BREO ELLIPTA), levocetirizine dihydrochloride (XYZAL), gabapentin (MANUFACTURER UNKNOWN), clonazepam (MANUFACTURER UNKNOWN) and fluvoxamine maleate (LUVOX); all for an unknown indication from an unknown date and unknown if ongoing. On 09May2021 at 04:00, the patient woke up with fever chills and a headache. As that day progressed, the patient developed body aches, severe fatigue, a mild fever (100.7) and cough. The patient's asthma was also mildly agitated. The events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. Therapeutic measures taken included TYLENOL (1000mg) at 6am, 12pm, and 11pm. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever chills, headache, body aches, severe fatigue, fever, cough and asthma also seemed mildly agitated were resolved on 10May2021.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Satellite lesions, headache, fever (101F on 3/25/03). BP on 3/22/03 was 230/113 (normally 112/70), now on 3/28/03 it is 114/62. Headache and photophobia improved and blurry vision improved. Has left chest pain and scapular area pain; dull but slightly increased with inspiration. Had cowpox scar on other arm became swollen and redness decreasing on 3/26/03; still red on 3/28/03. Is being followed by PCP.
This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (Arm was a little sore), VACCINATION SITE WARMTH (spot warm to the touch), VACCINATION SITE SWELLING (spot slightly raised) and VACCINATION SITE ERYTHEMA (Red spot below the injection site) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. No Medical History information was reported. On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm was a little sore). On 18-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red spot below the injection site). On 19-Jan-2021, the patient experienced VACCINATION SITE WARMTH (spot warm to the touch) and VACCINATION SITE SWELLING (spot slightly raised). On 10-Jan-2021, PAIN IN EXTREMITY (Arm was a little sore) had resolved. At the time of the report, VACCINATION SITE WARMTH (spot warm to the touch), VACCINATION SITE SWELLING (spot slightly raised) and VACCINATION SITE ERYTHEMA (Red spot below the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. Treatment information was not provided.
17 year old stated she was feeling lightheaded and anxious.  Client slump to the floor.  Father caught client sustained no injuries.  No loss of consciousness. B/P 104/62.  Client laid in supine position for 10 minutes.  Transfered to observation area.  rechecked B/P 108/72 P102 R 20.  Client stated she felt better.  Patient sat in wheelchair for 30 minutes.  Rechecked B/P 110/70.  Client released for father to take home.
evening after injection, pt started to have pain, redness, swelling that eventually migrated down past antecubital area. Not quite circumferential, but almost entire upper arm
Information has been received from a 60 year old male consumer with high blood pressure and no allergies or known drug reactions who on 23-NOV-2007 was vaccinated (route and site not reported) with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot#655766/0038U). Concomitant therapy included valsartan (DIOVAN). On 23-NOV-2007, post vaccination, the patient developed pain, sore and sleeping problems. The patient did receive unspecified medical attention. No diagnostic lab test were performed. At the time of this report the patient's pain, sore and sleeping problems had not recovered. Additional information has been requested.
Approximately 24 hours after receiving second Moderna vaccine patient developed right sided weakness which prompted a trip to the emergency room. There a head CT was performed and was negative. Patient was then admitted for further testing and a MRI of the brain performed the following day reveled a acute ischemic stroke.  Patient was discharged to acute patient rehab and symptoms improved but have not resolved.
CHILLS; ARM PAIN; UNSPECIFIED HEADACHE/ PIERCING HEADACHE; FATIGUE; NAUSEA; MUSCLE ACHES; This spontaneous report received from a consumer concerned nine patients. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 1805025 expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. Concomitant medications included paracetamol. On 06-APR-2021, the subject experienced chills. On 06-APR-2021, the subject experienced arm pain. On 06-APR-2021, the subject experienced unspecified headache/ piercing headache. On 06-APR-2021, the subject experienced fatigue. On 06-APR-2021, the subject experienced nausea. On 06-APR-2021, the subject experienced muscle aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from unspecified headache/ piercing headache, chills, fatigue, nausea, arm pain, and muscle aches. This report was non-serious. This case, from the same reporter is linked to 20210413715.
Woke up in the middle of the night with all over body pain and stiffness in joints like I couldn't move, diarrhea and vomiting and pain and burning sensation in digestive bowel. I couldn't keep anything down from water, Pedialyte, ice chips. my mom took me to doctor this morning on Tuesday 4, 2022 and was given anti-nausea medicine .
Pt tested positive for COVID-19 on 2/10/2021 and was hospitalized on 2/15/2021 and deceased on 2/18/2021 at the hospital of admission, per caregiver.
Information has been received from a physician concerning a "10 year old" male who on an unspecified date was vaccinated with the first dose of VARIVAX (Merck) (LOT# not reported). Subsequently, on an unspecified date the patient experienced shingles. Unspecified medical attention was sought. The patient recovered from shingles after on unknown therapy. After experiencing shingles, on an unspecified date, the patient was administered the second dose of VARIVAX (Merck). This is the second of two sibling cases received from same source. Additional information has been requested.
Client traveling received below vaccines for trip. Client called 5/10/02 reported L arm was too sore to move, trouble lifting, warm but not swollen or red. ENC cold compress, Ibuprofen, if not better by Monday 5/13/02 to see PMD> Left message 5/14/02 RTC from client 5/17/02-need to return call, no RN available at time. Made appt with Dr 5/31/02 3pm.
Received pneumococcal vaccine, lot # 0926N, on 11/10/04. Developed cellulitis, itching and rash later that day. Daughter applied warm compresses to site and gave Benadryl 50mg.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient (not pregnant) received BNT162b2 (BNT162B2), on 01Aug2022 as dose 1, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Rheumatoid arthritis" (unspecified if ongoing); "Drug allergy" (unspecified if ongoing), notes: Relevant past drug history:, Name of Drug as Reported: No, Reaction: Allergy. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Oct2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Positive, notes: Positive test 2 days after completing treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19 which includes Paxlovid from 23Oct2022 to 27Oct2022.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a pharmacist refers to a patient of unknown age. The patient was vaccinated SC with a dose of ZOSTAVAX (Lot number and dose not reported) on 29-OCT-2012 which expired on 25-OCT-2012. No adverse effects were reported. Additional information has been requested.
There was no adverse reaction. Patient was given PROQUAD, PENTACEL and varicella. CDC was contact for guidance. We were informed that we need to complete a VAERS report. Mother was contacted she states patient did not have any adverse reaction.
1 day after blurry vision felt like pass out. 8 days later lymph nodes by collarbone extremely swollen and painful.  3 weeks later severe right abdominal pain right side. 2 ct scans and transvagional sonogram and numerous blood tests and Er visits twice in one week, regular dr 3 visits in one week gynecologist and gastroenterologist each in one week.
Rash at injection site. Rash is itchy, warm and raised. About 3 in wide and 2 in long.
fever; tingling sensation on skin; felt like pin prickling or like bugs crawling across her skin; uncomfortable; This case was reported by a consumer via call center representative and described the occurrence of fever in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In January 2019, the patient received the 2nd dose of Shingrix. On an unknown date, less than 9 months after receiving Shingrix, the patient experienced fever, tingling skin, sensation of foreign body and discomfort. On an unknown date, the outcome of the fever was recovered/resolved and the outcome of the tingling skin, sensation of foreign body and discomfort were unknown.   It was unknown if the reporter considered the fever, tingling skin, sensation of foreign body and discomfort to be related to Shingrix.  Additional case details were provided as follows: The age at vaccination was not reported but it could be 71 years or 72 years. The patient stated, she experienced fever which was resolved. About 3 or 4 months before the reporting date, she experienced tingling sensation on skin that moved around all over her body and felt like pin prickling or like bugs crawling across her skin and was very uncomfortable.   The patient had not seen a physician about this issue till the time of reporting. The patient did not consent to follow-up and she declined follow up with her physician until she had a chance to be seen by him.
Sinus and ear infection; Ear infection; "Very exhausted"/extremely tired; Dizzy; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Dizzy), SINUSITIS (Sinus and ear infection), EAR INFECTION (Ear infection) and FATIGUE ("Very exhausted"/extremely tired) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided.  Concomitant products included LEVOTHYROXINE, ATORVASTATIN and TELMISARTAN for an unknown indication.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced DIZZINESS (Dizzy) and FATIGUE ("Very exhausted"/extremely tired). On an unknown date, the patient experienced SINUSITIS (Sinus and ear infection) and EAR INFECTION (Ear infection). The patient was treated with SULFAMETHOXAZOLE at a dose of 1 dosage form and TRIMETHOPRIM at a dose of 1 dosage form. At the time of the report, DIZZINESS (Dizzy), SINUSITIS (Sinus and ear infection), EAR INFECTION (Ear infection) and FATIGUE ("Very exhausted"/extremely tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment provided for dizziness was water and electrolytes.   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: DOB provided. Contact details updated. updated  event  verbatim 'very exhausted/extremely tired'.
"A couple" / received / first dose / 30AUG2018 / have not / received the next; This case was reported by a pharmacist via other manufacturer and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose on 30th August 2018).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional information was provided as follow: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix vaccine, which led to incomplete course of vaccination. The reporter declined to provide further adverse events details or information.  No additional adverse events reported.  No additional information reported. This case had been linked with US2021AMR170420, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR170420:Same reporter. Patient 2/2.
During check in, Pt stated that he had hives that started 1 week after his first Covid vaccine.Pt received 2nd Pfizer Covid 19 vaccine. During the post vaccine observation time, pt was slumped over in the chair and moaning. 0858 This nurse sat beside pt. Asked questions, pt did not answer. Attempted to assist pt to a sitting position and pt slid and was assisted to the floor. Pt lips were pink and pt was rolling on the floor and not answering direct questions. 0900 911 was called. 0902 Pt had gasping breaths. EpiPen administered in L thigh. Breathing improved.0908 Pt calm, pulse ox placed HR 92, sats 99%. 0910 Pt began rolling around again. 0913 Paramedics arrived.